Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/C148FEC4.svg?ark=w1%2F20260515%2FC148FEC4)](https://nobleid.org/work/w1/20260515/C148FEC4)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors